Related Experiment Video

Updated: Aug 2, 2025

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

548

Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society

Eric D Hamlett1, Lisi Flores-Aguilar2,3, Benjamin Handen4

  • 1Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

Molecular Syndromology
|April 17, 2023
PubMed

Insights

Research on Down syndrome (trisomy 21) is advancing our understanding of its molecular and cellular impacts. The Trisomy 21 Research Society conference highlighted new discoveries in biomarkers and therapies for T21-related conditions.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Developmental Biology

Background:

  • Down syndrome, caused by trisomy 21 (T21), presents complex challenges in understanding its molecular and cellular modifications.
  • The Trisomy 21 Research Society (T21RS) is a key organization driving research and clinical advancements in Down syndrome.

Purpose of the Study:

  • To summarize the latest discoveries presented at the T21RS virtual conference.
  • To highlight progress in understanding T21's impact on cellular processes, cognition, and comorbidities.
  • To showcase advancements in biomarkers and therapeutic strategies for Down syndrome.

Main Methods:

  • Virtual conference program held by T21RS (June 8-10, 2021).
  • Presentations and discussions involving 342 scientists, families, and industry representatives from over 25 countries.
  • Review of 91 abstracts covering diverse research areas related to T21.

Main Results:

  • Significant progress in understanding the molecular and cellular mechanisms of T21.
  • New insights into cognitive and behavioral changes associated with Down syndrome.
  • Exploration of comorbidities like Alzheimer's disease and Regression Disorder in T21.
  • Advancements in neuroscience, neurology, model systems, psychology, biomarkers, and therapeutic approaches.

Conclusions:

  • The conference demonstrated a strong and growing interest in Down syndrome research.
  • There is a continuing drive towards developing innovative biomarkers and therapies to improve health outcomes for individuals with T21.
Keywords:
BiomarkersClinical researchDown syndromeIntellectual disabilityPreclinical research

More Related Videos

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

3.8K
TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism10:58

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

Published on: December 28, 2010

17.0K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
130
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
224
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.9K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
130